Prosecution Insights
Last updated: November 20, 2026

Natalie M Moss, USPTO Patent Examiner

Listed by the USPTO as MOSS, NATALIE M

Tech Center 1600 • Art Units: 1651 1653

This examiner grants 31% of resolved cases

Analysis

MOSS, NATALIE M is assigned to Tech Center 1600 and art unit 1651. The profile covers 525 resolved cases, with an allowance rate of 30.7%, a 16.9% interview lift, and a median of 1416 days to allowance. The allowance figure indicates that prosecution outcomes in this record are more often non-allowance than allowance.

Genentech Inc., University of Florida Research Foundation Inc., and The Regents of the University of California are the listed top companies. The listed firms are Casimir Jones, S.C., MARSHALL, GERSTEIN & BORUN LLP, and OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. The case volume supports using the profile for portfolio planning. The interview measure supports considering interviews, but it does not outweigh the broader allowance pattern.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

30.7%
Allow Rate
-29.3% vs TC avg
607
Total Applications
+16.9%
Interview Lift
1416
Avg Prosecution Days
Based on 525 resolved cases, 2023–2026

Rejection Statute Breakdown

7.9%
§101 Eligibility
13.5%
§102 Novelty
45.0%
§103 Obviousness
29.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17964325 METHOD FOR MEDIUM TREATMENT BEFORE INOCULATION Non-Final OA Genentech, Inc.
17756842 MITOTHERAPEUTICS FOR THE TREATMENT OF BRAIN DISORDERS Non-Final OA The University of Florida Research Foundation, Inc.
18227801 Methods for Antimicrobial Susceptibility Testing Final Rejection The Regents of the University of California
17639210 PRESERVATION OF ORGANS FOR TRANSPLANT AND NON-TRANSPLANT SURGERIES Final Rejection The Regents of the University of Michigan
14239690 PROCESS FOR PRODUCING CELLULASES USING A FILAMENTOUS FUNGUS SUITABLE FOR A FERMENTER, HAVING A LOW VOLUMETRIC OXYGEN TRANSFER COEFFICIENT KLA Non-Final OA IFP ENERGIES NOUVELLES
17763723 CONCENTRATED PERFUSION MEDIUM Non-Final OA Boehringer Ingelheim International GmbH
17842762 FGF-18 IN GRAFT TRANSPLANTATION AND TISSUE ENGINEERING PROCEDURES Final Rejection MERCK PATENT GMBH
17439251 ISOLATION, ENRICHMENT AND EXPANSION OF CONE PROGENITOR CELLS AND USES THEREOF Non-Final OA Massachusetts Institute of Technology
17213417 COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION Final Rejection DANA-FARBER CANCER INSTITUTE, INC.
17688516 USE OF AN EXTRACELLULAR MATRIX (ECM) HYDROGEL AS AN ESOPHAGEAL SUBMUCOSAL FLUID CUSHION Non-Final OA University of Pittsburgh - Of the Commonwealth System of Higher Education
17879015 Method of Recovering Nitrogen and Sulfur Resources Through Anaerobic Fermentation Final Rejection SK Innovation Co., Ltd.
17906727 Upregulation of Cathelicidin Gene Expression as an Adjuvant to Other Treatments for Diseases Final Rejection The Board of Trustees of the Leland Stanford Junior University
17541558 FASTING MIMICKING KETOGENIC DIET (FMD) TO PROMOTE SKELETAL MUSCLE REGENERATION AND STRENGTH Final Rejection UNIVERSITY OF SOUTHERN CALIFORNIA
18601773 CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES FOR TREATMENT AND PREVENTION OF CANCER Final Rejection CEDARS-SINAI MEDICAL CENTER
17259784 INJECTION TECHNIQUES FOR THE TREATMENT OF CELLULITE Non-Final OA ENDO OPERATIONS LIMITED
17782801 COMPOSITION FOR TREATING OR PREVENTING AN ALLERGY OR ALLERGIC REACTION Final Rejection Aposcience AG
18277278 CELL SHEET SUPPORT, CELL SHEET LAMINATE AND METHOD FOR PRODUCING SAME Final Rejection FUKUOKA UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Natalie M Moss's allowance rate?

30.7% of resolved applications examined by Natalie M Moss were allowed (525 resolved cases), compared with 31.5% across Art Unit 1651 over the last five years.

Does an interview help with examiner Natalie M Moss?

This examiner's interview lift is +16.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Natalie M Moss take to allow a patent?

Applications allowed by Natalie M Moss took 1,416 days on average from filing to allowance.

Which art unit does examiner Natalie M Moss work in?

Natalie M Moss examines applications in Art Unit 1651 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month